Archives
Human iPSC-Derived Sensory Neurons Model HSV-1 Latency and R
2026-04-30
Human iPSC-Derived Sensory Neurons as a Platform for Studying HSV-1 Latency and Reactivation
Study Background and Research Question
Herpes simplex virus type 1 (HSV-1) is a ubiquitous human pathogen responsible for a spectrum of diseases, from recurrent oral lesions to severe neurological complications such as encephalitis. After initial lytic infection of mucosal epithelial cells, HSV-1 establishes lifelong latency in peripheral neurons, particularly sensory and autonomic ganglia. During latency, the viral genome persists in a silenced state, periodically reactivating to cause recurrent disease episodes. While animal models have been pivotal in elucidating HSV-1 latency, significant species-specific differences limit the translation of these findings to human biology. The lack of scalable, physiologically relevant human neuronal models has been a major barrier to investigating the neuron-intrinsic mechanisms governing HSV-1 latent infection and reactivation (Oh et al., 2025).Key Innovation from the Reference Study
Oh et al. (2025) address this gap by developing a robust protocol to rapidly differentiate human-inducible pluripotent stem cells (hiPSCs) into sensory neurons. These hiPSC-derived neurons are functionally mature, excitable, and exhibit expression of key ion channels. Most importantly, the study demonstrates that these neurons can support the full spectrum of HSV-1 infection states—acute lytic replication, authentic latency, and stimulus-induced reactivation—recapitulating critical hallmarks observed in vivo. This system represents a significant advancement, providing a scalable and genetically tractable platform for mechanistic studies of HSV-1 latency in a human context (Oh et al., 2025).Methods and Experimental Design Insights
The authors established a stepwise differentiation protocol to generate sensory neurons from hiPSCs. These neurons were characterized by electrophysiology, demonstrating functional excitability and expression of voltage-gated sodium and potassium channels. For HSV-1 infection studies, the neurons were exposed to virus under conditions optimized to favor latency. Key indicators of latency included the absence of infectious virion production, minimal lytic gene expression, robust expression of the latency-associated transcript (LAT), and deposition of repressive histone modifications (H3K9me3 and H3K27me3) on the viral genome. Reactivation was induced using known pharmacologic stimuli, such as forskolin and PI3K inhibitors, which are consistent with established triggers in animal models (Oh et al., 2025).Protocol Parameters
- assay | hiPSC sensory neuron differentiation | 14-21 days | applicable to modeling human neuronal phenotypes | Ensures physiological relevance and scalability | paper
- assay | HSV-1 infection MOI | 0.1-1.0 | applicable to latency establishment in vitro | Balances sufficient infection with minimal cytotoxicity | paper
- assay | Forskolin-induced reactivation | 10 μM, 24-48 h | applicable to reactivation protocols | Mimics cAMP pathway stimulation to reactivate latent HSV-1 | paper
- assay | PI3K inhibitor-induced reactivation | 1 μM, 24-48 h | alternative reactivation stimulus | Reflects established triggers for viral reactivation | paper
- assay | Chromatin immunoprecipitation (ChIP) | H3K9me3, H3K27me3 | applicable to epigenetic profiling of HSV-1 genomes | Validates silencing of lytic promoters during latency | paper
Core Findings and Why They Matter
The study convincingly shows that hiPSC-derived sensory neurons can serve as a faithful model for HSV-1 latency. Key findings include:- Efficient Latency Establishment: Infected neurons exhibited minimal production of infectious virus and low lytic gene expression, accompanied by abundant LAT expression and the presence of repressive chromatin marks on the viral genome (Oh et al., 2025).
- Stimulus-Responsive Reactivation: Pharmacologic triggers (forskolin, PI3K inhibitors) successfully reactivated latent HSV-1, mirroring in vivo reactivation pathways (Oh et al., 2025).
- Physiological Relevance: The neurons retained electrophysiological properties and molecular markers characteristic of human sensory neurons, supporting their suitability for translational studies.
Comparison with Existing Internal Articles
Recent internal reviews, such as "Reimagining FGFR3 Pathway Inhibition", have highlighted the use of potent small molecule inhibitors, including SU 5402, in neuronal models to dissect cell signaling and validate therapeutic targets. While SU 5402 has been extensively characterized in cancer biology and multiple myeloma research for its impact on apoptosis and cell cycle arrest (internal_article), its application in neuronal systems is primarily mechanistic—providing insights into receptor tyrosine kinase (RTK) signaling that may intersect with pathways relevant to viral latency and reactivation. The reference study does not directly employ RTK inhibitors but establishes a platform where such tools (including SU 5402) could be deployed to investigate the interplay between host signaling and HSV-1 latency (internal_article).Limitations and Transferability
Despite the robust nature of this model, several limitations warrant consideration:- In Vitro Context: While the hiPSC-derived neuron system recapitulates key aspects of human sensory neurons, it cannot fully model the in vivo microenvironment, including interactions with immune cells and supporting glia.
- Genetic and Epigenetic Diversity: iPSC lines may exhibit donor-specific differences in susceptibility to infection and responses to stimuli.
- Scalability to High-Throughput Screens: While more scalable than primary neuron cultures, differentiation protocols can remain variable and labor-intensive.